Q1 2025 Anika Therapeutics Inc Earnings Call Transcript

May 9, 2025 / 12:30 PM GMT

Release Date Price: €11.5 (-11.54%)

Transcript 10-Q8-K

Key Points

Positve

Anika Therapeutics Inc (ANIK) reported strong growth in its commercial channel, with revenue up 18% year over year.
The company achieved 33% growth in its regenerative solutions portfolio, driven by the success of the Integrity implant system.
Anika Therapeutics Inc (ANIK) has made significant progress in its strategic initiatives, focusing on its proprietary hyaluronic acid technologies.
Cost-saving measures have been effective, with operating expenses down 12% year over year.
The company is on track for the anticipated US approvals of Halofast and Singal, which are expected to be market-driving forces in their respective fields.

Negative

Overall revenue for the first quarter was down 10% compared to the same period in 2024, primarily due to pricing pressure in the OEM channel.
The OEM channel revenue decreased by 23% due to lower pricing for Monovik and Orthovisk in the US.
Gross margin declined to 56%, down 9 percentage points from the previous year, impacted by lower sales and higher manufacturing costs.
The company faced ongoing pricing challenges in the domestic OA pain market.
Manufacturing challenges led to lower yields and increased scrap, affecting the production of Monovik and Singal.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ANIK.OQ - Anika Therapeutics Inc
Q1 2025 Anika Therapeutics Inc Earnings Call
May 09, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning ladies and gentlemen. Welcome to Anika's first quarter earnings conference call. At this time, online journal listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press 0 for the operator. I will now turn the call over to Matt Hall, director, corporate development and investor relations. Please proceed.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you.

Good morning and thank you for joining us for Anika's first quarter 2025 conference

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.